Intensity Therapeutics Inc

NASDAQ:INTS

0.28

-0.01 (-3.09%)

7:57:34 PM EDT: $0.28 0.00 (-0.67%)

Intensity Therapeutics Inc Stock, NASDAQ:INTS

1 Enterprise Drive, Suite 430, Shelton, Connecticut 06484-4779

United States of America

Phone: +1.203.221.7381

Number of Employees: 16

http://www.intensitytherapeutics.com

Description

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.